Norway· NO-ID_B34588D9-4F20-4FCA-AEA6-8FE3631DE05F
Recarbrio
A imipenem, cilastatin and relebactam product containing cilastatin sodium + imipenem + relebactam, registered in Norway by MSD. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Imipenem, cilastatin and relebactam is registered in 11 of 19 countries.
Countries holding a registration under ATC J01DH56 (imipenem, cilastatin and relebactam), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Imipenem, cilastatin and relebactam · ATC J01DH56
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cilastatin Sodium + Imipenem + Relebactam
- Manufacturer
- MSD
- Country
- Norway (NO)
- ATC code
- J01DH56
- ATC class
- Imipenem, cilastatin and relebactam
- Defined daily dose
- 2 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_B34588D9-4F20-4FCA-AEA6-8FE3631DE05F
- no_varenummer24528925
- gtin191778022889
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Imipenem, cilastatin and relebactam in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRECARBRIOMerck Sharp & Dohme B.V., Haarlem
- SpainRECARBRIO 500 mg/500 mg/250 mg POLVO PARA SOLUCION PARA PERFUSIONMerck Sharp & Dohme B.V.
- FinlandRecarbrioMerck Sharp & Dohme B.V.
- FranceRECARBRIO 500 mg/500 mg/250 mg, poudre pour solution pour perfusionMERCK SHARP & DOHME (PAYS-BAS)
- United KingdomRecarbrio 500mg/500mg/250mg powder for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- IrelandRecarbrio 500 mg/500 mg/250 mg powder for solution for infusionMerck Sharp & Dohme BV,
- NetherlandsRecarbrio 500 mg/500 mg/250 mg, poeder voor oplossing voor infusieMerck Sharp & Dohme B.V.
- SwedenRecarbrio 500 mg/500 mg/250 mg Pulver till infusionsvätska, lösningMerck Sharp & Dohme BV
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Recarbrio
- Liechtenstein · Recarbrio
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/378a4f46-c9c9-4b2e-8aa2-1e857ad09058 GET /v1/drugs/378a4f46-c9c9-4b2e-8aa2-1e857ad09058?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver til infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Imipenem, cilastatin og relebaktam",
"merkevare_id": "ID_B34588D9-4F20-4FCA-AEA6-8FE3631DE05F",
"name_form_strength": "Recarbrio pulv til inf væske oppl 500 mg/500 mg/250 mg",
"prescription_group": "C"
}See everything about imipenem, cilastatin and relebactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.